Telavant

Company, is developing innovative therapies to.

Launch date

2022

Employees

Market cap

Net debt

-

Enterprise valuation

$7.1b (Public information from Oct 2023)

New York City New York (HQ)

http://telavanttx.com

https://www.linkedin.com/company/telavant/

Get premium to view all results

Date	Investors	Amount	Round
Jan 2021	investor	$0.0	round
Oct 2023*	Roche	$7.1b Valuation: $7.1b	Acquisition
Total Funding		000k